NASDAQ · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · LARGE CAP
ICU Medical Inc. ICUI
19 fiscal years on record · USD · FY2025 reported · SEC filings only
In brief
What this company does
Written from the business description in ICU MEDICAL INC/DE's annual report to the U.S. Securities and Exchange Commission, filed 19 February 2026. Every sentence was checked against that document before publication.
Growth
USD 2.2B
Revenue, FY2025 · full 19-year series below
Revenue $B
Net income $B
FY2025 · Revenue 2.2 · Net income 0.0
Compound annual growth
−0.7%
+11.9%
+20.6%
+14.8%
−61.5%
−33.8%
−21.9%
−62.5%
−36.3%
−24.8%
+8.2%
−14.1%
3 yrs
5 yrs
10 yrs
15 yrs
Revenue compounded at +11.9% a year over five years.
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
Profitability
0 cents
of every revenue dollar became profit
Operating margin
Net margin
FY2025 · Operating 1.9% · Net 0.0%
ROE
FY2025 · ROE 0.0%
Each USD of equity produced 0 cents of profit this year.
The 19-year record
19 fiscal years
Every figure from documents filed with the SEC · USD
row low → row highnegative
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue $B | 2.2 | 2.4 | 2.3 | 2.3 | 1.3 | 1.3 | 1.3 | 1.4 | 1.3 | 0.4 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 | 0.2 | 0.2 |
| Operating income $B | 0.0 | 0.0 | 0.0 | −0.0 | 0.1 | 0.1 | 0.1 | 0.0 | −0.0 | 0.1 | 0.1 | 0.0 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 |
| EBITDA $B | 0.2 | 0.3 | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 |
| Income tax $B | 0.0 | 0.1 | −0.0 | −0.0 | 0.0 | 0.0 | 0.0 | −0.0 | −0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net income $B | 0.0 | −0.1 | −0.0 | −0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Free cash flow $B | 0.1 | 0.1 | 0.1 | −0.2 | 0.2 | 0.1 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| EPS, diluted $ | 0.03 | −4.83 | −1.23 | −3.11 | 4.74 | 4.02 | 4.69 | 1.33 | 3.29 | 3.66 | 2.73 | 1.68 | 2.65 | 2.80 | 3.15 | 2.16 | 1.67 | 1.67 | 1.51 |
| Dividend / sh $ | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
| Payout % | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
| ROE % | 0.0 | −5.8 | −1.4 | −4.0 | 6.6 | 6.0 | 7.7 | 2.3 | 7.4 | 10.2 | 8.3 | 5.4 | 9.4 | 11.6 | 15.1 | 11.2 | 9.7 | 9.6 | · |
| Shares out B | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | · |
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
Provenance
Company facts, as filed
How we verify · 0 failures in 93 reconciliationsAUDITED
Reconciled in 19 of 19 fiscal years. 2 checks could not be computed.
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivitySurgical & Medical Instruments & Apparatus
Listed onNASDAQ
Incorporated inDelaware
Fiscal year endsDecember 31
Data on record since2007